
Assessing Vocal Function After Chemoradiation for Advanced Laryngeal Carcinoma
Gayle E. Woodson, MD;
Clark A. Rosen, MD;
Thomas Murry, PhD;
Ram Madasu, MD;
Frank Wong, MD;
Arne Hengesteg;
K. Thomas Robbins, MD
Arch Otolaryngol Head Neck Surg. 1996;122(8):858-864.
Abstract
 |  |
Objective To identify objective parameters that could serve as valid indicators of vocal function in evaluating patients treated at multiple centers for head and neck cancer.
Design Objective measures of voice were validated against functional outcome measures of voice and communication.
Setting A multidisciplinary university-based ambulatory head and neck cancer clinic.
Subjects Fifteen patients at varying posttreatment intervals after chemoradiation therapy for head and neck cancer and 5 volunteers with no cancer but with a history of heavy smoking and drinking.
Main Outcome Measures Acoustic and aerodynamic parameters were measured in patients with head and neck cancer after treatment with combined chemotherapy and irradiation and in control subjects. Communicative function was assessed by perceptual assessment of recorded voice samples, by a clinician-based communication score, and by patient self-rating of voice and communication.
Results Both perceptual analyis and communication score were concordant with patient self-rating of voice and communication ability. Acoustic measures were abnormal in patients, and jitter scores correlated with listener ratings of perceived voice quality. However, acoustic measures did not relate to communication function, as assessed by either the patient or the clinician. Laryngeal resistance demonstrated a significant correlation with both patient and observer assessments of voice quality and communication function. Laryngeal resistance was on average twice as high in patients who complained of voice fatigue, but this difference was not statistically significant.
Conclusions Laryngeal resistance, determined during standardized phonation, is a reliable objective parameter of vocal function after chemoradiation therapy for head and neck cancer. A standardized clinician-based communication scale holds promise as a useful tool. Acoustic measures reflect the sound of the voice but not the ability to communicate effectively.
Arch Otolaryngol Head Neck Surg. 1996;122:858-864
Author Affiliations
From the Department of Otolaryngology, University of Tennessee, Memphis.
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
Voice-Related Quality of Life After Treatment of Laryngeal Cancer
Oridate et al.
Arch Otolaryngol Head Neck Surg 2009;135:363-368.
ABSTRACT
| FULL TEXT
Voice and Swallowing in Patients Enrolled in a Larynx Preservation Trial
Carrara-de Angelis et al.
Arch Otolaryngol Head Neck Surg 2003;129:733-738.
ABSTRACT
| FULL TEXT
Quality-of-Life Assessment After Supradose Selective Intra-arterial Cisplatin and Concomitant Radiation (RADPLAT) for Inoperable Stage IV Head and Neck Squamous Cell Carcinoma
Ackerstaff et al.
Arch Otolaryngol Head Neck Surg 2002;128:1185-1190.
ABSTRACT
| FULL TEXT
The Evolving Role of Combined Modality Therapy in Head and Neck Cancer
Robbins
Arch Otolaryngol Head Neck Surg 2000;126:265-269.
FULL TEXT
Acoustic and Perceptual Evaluation of Voice and Speech Quality: A Study of Patients With Laryngeal Cancer Treated With Laryngectomy vs Irradiation
Finizia et al.
Arch Otolaryngol Head Neck Surg 1999;125:157-163.
ABSTRACT
| FULL TEXT
|